glp-1 market share Analogues Report, Growth and Forecast GLP-1 Agonists Market Size, Share,
Description
doi: 10.1111/j.1467-789X.2004.00144.x [DOI] [PubMed] [Google Scholar] 8

As patient access improves and awareness spreads, the demand for these therapies will increase, despite challenges like high treatment costs and market competition. - Shambhu Nath Jha, Principal Consultant at Fact MR
-agonists-market-key-insight.png)
Published: March 19, 2026 | Last Updated: July 10, 2026 | Version: 1.3

In addition, the coprimary end point of weight reduction of 5% was achieved in 86% of participants in the group receiving semaglutide and 32% of those randomized to placebo

Low incidence of anti-drug antibody in type 2 diabetes patients treated with once-weekly dulaglutide

In addition, animal studies (not yet demonstrated in humans) suggest that there is a link to thyroid cancer risk